{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:08:44Z","timestamp":1794074924201,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation-Youth Project","award":["NO.7234361"],"award-info":[{"award-number":["NO.7234361"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03641-w","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:55:34Z","timestamp":1735883734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of a pathogenic SDHD mutation in a Chinese family with hereditary head and neck paraganglioma: implications for genetic counseling and management"],"prefix":"10.1186","volume":"23","author":[{"given":"Pu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"2","key":"3641_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.eprac.2022.10.002","volume":"29","author":"L Sandow","year":"2023","unstructured":"Sandow L, Thawani R, Kim MS, Heinrich MC. Paraganglioma of the Head and Neck: a review. Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists. 2023;29(2):141\u20137.","journal-title":"Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists"},{"issue":"5","key":"3641_CR2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hed.21790","volume":"34","author":"K Papaspyrou","year":"2012","unstructured":"Papaspyrou K, Mewes T, Rossmann H, Fottner C, Schneider-Raetzke B, Bartsch O, Schreckenberger M, Lackner KJ, Amedee RG, Mann WJ. Head and neck paragangliomas: report of 175 patients (1989\u20132010). Head Neck. 2012;34(5):632\u20137.","journal-title":"Head Neck"},{"issue":"Suppl 1","key":"3641_CR3","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1055\/s-0030-1270447","volume":"90","author":"CC Boedeker","year":"2011","unstructured":"Boedeker CC. [Paragangliomas and paraganglioma syndromes]. Laryngo- rhino- otologie. 2011;90(Suppl 1):S56\u201382.","journal-title":"Laryngo- rhino- otologie"},{"issue":"4","key":"3641_CR4","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00261-019-02044-w","volume":"45","author":"VS Katabathina","year":"2020","unstructured":"Katabathina VS, Rajebi H, Chen M, Restrepo CS, Salman U, Vikram R, Menias CO, Prasad SR. Genetics and imaging of pheochromocytomas and paragangliomas: current update. Abdom Radiol (NY). 2020;45(4):928\u201344.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"3641_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/cen.15070","volume":"101","author":"M Darrat","year":"2024","unstructured":"Darrat M, Lau L, Leonard C, Cooke S, Shahzad MA, McHenry C, McCance DR, Hunter SJ, Mullan K. Clinical management and outcome of head and neck paragangliomas (HNPGLs): a single centre retrospective study. Clin Endocrinol. 2024;101(3):243\u20138.","journal-title":"Clin Endocrinol"},{"issue":"10","key":"3641_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jop.13286","volume":"51","author":"C Valero","year":"2022","unstructured":"Valero C, Ganly I. Paragangliomas of the head and neck. J oral Pathol Medicine: Official Publication Int Association Oral Pathologists Am Acad Oral Pathol. 2022;51(10):897\u2013903.","journal-title":"J oral Pathol Medicine: Official Publication Int Association Oral Pathologists Am Acad Oral Pathol"},{"issue":"5","key":"3641_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4149\/neo_2018_181208N933","volume":"66","author":"A Guha","year":"2019","unstructured":"Guha A, Musil Z, Vicha A, Zelinka T, Pacak K, Astl J, Chovanec M. A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas. Neoplasma. 2019;66(5):671\u201380.","journal-title":"Neoplasma"},{"issue":"6","key":"3641_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/hed.23436","volume":"36","author":"CC Boedeker","year":"2014","unstructured":"Boedeker CC, Hensen EF, Neumann HP, Maier W, van Nederveen FH, Su\u00e1rez C, Kunst HP, Rodrigo JP, Takes RP, Pellitteri PK, et al. Genetics of hereditary head and neck paragangliomas. Head Neck. 2014;36(6):907\u201316.","journal-title":"Head Neck"},{"issue":"4","key":"3641_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4158\/EP14481.RA","volume":"21","author":"K Pacak","year":"2015","unstructured":"Pacak K, Wimalawansa SJ. Pheochromocytoma and paraganglioma. Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists. 2015;21(4):406\u201312.","journal-title":"Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists"},{"issue":"4","key":"3641_CR10","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.3390\/ijms24044045","volume":"24","author":"F Bouillaud","year":"2023","unstructured":"Bouillaud F. Inhibition of succinate dehydrogenase by pesticides (SDHIs) and energy metabolism. Int J Mol Sci. 2023;24(4):4045.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3641_CR11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/jso.24961","volume":"117","author":"A Asban","year":"2018","unstructured":"Asban A, Kluijfhout WP, Drake FT, Beninato T, Wang E, Chomsky-Higgins K, Shen WT, Gosnell JE, Suh I, Duh QY. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center. J Surg Oncol. 2018;117(6):1217\u201322.","journal-title":"J Surg Oncol"},{"key":"3641_CR12","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"Fishbein L, Khare S, Wubbenhorst B, DeSloover D, D\u2019Andrea K, Merrill S, Cho NW, Greenberg RA, Else T, Montone K, et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun. 2015;6:6140.","journal-title":"Nat Commun"},{"issue":"2","key":"3641_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/joim.12869","volume":"285","author":"A Muth","year":"2019","unstructured":"Muth A, Crona J, Gimm O, Elmgren A, Filipsson K, Stenmark Askmalm M, Sandstedt J, Tengvar M, Tham E. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. J Intern Med. 2019;285(2):187\u2013204.","journal-title":"J Intern Med"},{"issue":"5","key":"3641_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1590\/2359-3997000000299","volume":"61","author":"PT Kavinga Gunawardane","year":"2017","unstructured":"Kavinga Gunawardane PT, Grossman A. The clinical genetics of phaeochromocytoma and paraganglioma. Arch Endocrinol Metab. 2017;61(5):490\u2013500.","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"3641_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.beem.2010.05.001","volume":"24","author":"G Opocher","year":"2010","unstructured":"Opocher G, Schiavi F. Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab. 2010;24(6):943\u201356.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3641_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12105-017-0803-4","volume":"11","author":"MD Williams","year":"2017","unstructured":"Williams MD. Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol. 2017;11:278\u201387.","journal-title":"Head Neck Pathol"},{"issue":"3","key":"3641_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41436-018-0106-5","volume":"21","author":"S Richter","year":"2019","unstructured":"Richter S, Gieldon L, Pang Y, Peitzsch M, Huynh T, Leton R, Viana B, Ercolino T, Mangelis A, Rapizzi E, et al. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma. Genet Medicine: Official J Am Coll Med Genet. 2019;21(3):705\u201317.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"key":"3641_CR18","doi-asserted-by":"crossref","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Current protocols in human genetics 2013, Chap. 7:Unit7.20.","DOI":"10.1002\/0471142905.hg0720s76"},{"issue":"3","key":"3641_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310\u20135.","journal-title":"Nat Genet"},{"issue":"7","key":"3641_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381.","journal-title":"Nat Protoc"},{"issue":"4","key":"3641_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361\u20132.","journal-title":"Nat Methods"},{"issue":"9","key":"3641_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/jmg.39.9.617","volume":"39","author":"BE Baysal","year":"2002","unstructured":"Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet. 2002;39(9):617\u201322.","journal-title":"J Med Genet"},{"issue":"1","key":"3641_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12105-022-01435-8","volume":"16","author":"O Mete","year":"2022","unstructured":"Mete O, Wenig BM. Update from the 5th edition of the world health organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms. Head Neck Pathol. 2022;16(1):123\u201342.","journal-title":"Head Neck Pathol"},{"issue":"9","key":"3641_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/jmg.2004.019224","volume":"41","author":"BE Baysal","year":"2004","unstructured":"Baysal BE, Willett-Brozick JE, Filho PA, Lawrence EC, Myers EN, Ferrell RE. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet. 2004;41(9):703\u20139.","journal-title":"J Med Genet"},{"issue":"6","key":"3641_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","volume":"55","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Ascher DB, Pires DEV, Barnes DR, Vialard L, Casey RT, Bradshaw N, Adlard J, Aylwin S, Brennan P. Tumour risks and genotype\u2013phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. J Med Genet. 2018;55(6):384\u201394.","journal-title":"J Med Genet"},{"key":"3641_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-7-1","volume":"7","author":"JP Bayley","year":"2006","unstructured":"Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, et al. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and\/or pheochromocytoma. BMC Med Genet. 2006;7:1.","journal-title":"BMC Med Genet"},{"issue":"1","key":"3641_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/cancers11010103","volume":"11","author":"JA Rijken","year":"2019","unstructured":"Rijken JA, Van Hulsteijn LT, Dekkers OM, Niemeijer ND, Leemans CR, Eijkelenkamp K, Van Der Horst-Schrivers AN, Kerstens MN, Van Berkel A, Timmers HJ. Increased mortality in SDHB but not in SDHD pathogenic variant carriers. Cancers. 2019;11(1):103.","journal-title":"Cancers"},{"issue":"11","key":"3641_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/jmg.2008.058560","volume":"45","author":"BE Baysal","year":"2008","unstructured":"Baysal BE. Clinical and molecular progress in hereditary paraganglioma. J Med Genet. 2008;45(11):689\u201394.","journal-title":"J Med Genet"},{"issue":"7","key":"3641_CR29","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1136\/jmg.2003.011551","volume":"41","author":"RF Badenhop","year":"2004","unstructured":"Badenhop RF, Jansen JC, Fagan PA, Lord RS, Wang ZG, Foster WJ, Schofield PR. The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features. J Med Genet. 2004;41(7):e99.","journal-title":"J Med Genet"},{"key":"3641_CR30","unstructured":"Guha A. New methods of classification and prognosis in paragangliomas and pheochromocytomas. 2023."},{"issue":"1","key":"3641_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/16089677.2020.1838161","volume":"26","author":"C Bruce-Brand","year":"2021","unstructured":"Bruce-Brand C, van Wyk AC. Prevalence of succinate dehydrogenase deficiency in paragangliomas and phaeochromocytomas at a tertiary hospital in Cape Town: a retrospective review. J Endocrinol Metabolism Diabetes South Afr. 2021;26(1):9\u201315.","journal-title":"J Endocrinol Metabolism Diabetes South Afr"},{"issue":"12","key":"3641_CR32","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/jmedgenet-2012-101192","volume":"49","author":"LT van Hulsteijn","year":"2012","unstructured":"van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JW, Corssmit EP. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis. J Med Genet. 2012;49(12):768\u201376.","journal-title":"J Med Genet"},{"issue":"10","key":"3641_CR33","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"L Amar","year":"2007","unstructured":"Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP, et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab. 2007;92(10):3822\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3641_CR34","doi-asserted-by":"crossref","unstructured":"Aghamir SMK, Heshmat R, Ebrahimi M, Ketabchi SE, Parichehreh Dizaji S, Khatami F. The impact of succinate dehydrogenase gene (SDH) mutations in renal cell carcinoma (RCC): a systematic review. OncoTargets Therapy 2019:7929\u201340.","DOI":"10.2147\/OTT.S207460"},{"issue":"8","key":"3641_CR35","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1210\/jc.2008-2504","volume":"94","author":"N Burnichon","year":"2009","unstructured":"Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94(8):2817\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3641_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/jmedgenet-2019-106214","volume":"57","author":"JP Bayley","year":"2020","unstructured":"Bayley JP, Bausch B, Rijken JA, Van Hulsteijn LT, Jansen JC, Ascher D, Pires DEV, Hes FJ, Hensen EF, Corssmit EP. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma\u2013paraganglioma. J Med Genet. 2020;57(2):96\u2013103.","journal-title":"J Med Genet"},{"issue":"4","key":"3641_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cen.14594","volume":"96","author":"ST Williams","year":"2022","unstructured":"Williams ST, Chatzikyriakou P, Carroll PV, McGowan BM, Velusamy A, White G, Obholzer R, Akker S, Tufton N, Casey RT. SDHC phaeochromocytoma and paraganglioma: a UK-wide case series. Clin Endocrinol. 2022;96(4):499\u2013512.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"3641_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","volume":"11","author":"JP Bayley","year":"2010","unstructured":"Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA, et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 2010;11(4):366\u201372.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3641_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1158\/1078-0432.CCR-10-0420","volume":"17","author":"HP Kunst","year":"2011","unstructured":"Kunst HP, Rutten MH, de M\u00f6nnink JP, Hoefsloot LH, Timmers HJ, Marres HA, Jansen JC, Kremer H, Bayley JP, Cremers CW. SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma. Clin cancer Research: Official J Am Association Cancer Res. 2011;17(2):247\u201354.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"issue":"6","key":"3641_CR40","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1086\/324413","volume":"69","author":"AP Gimenez-Roqueplo","year":"2001","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, R\u00f6tig A, Jeunemaitre X. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet. 2001;69(6):1186\u201397.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"3641_CR41","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41431-018-0116-4","volume":"26","author":"BL Heesterman","year":"2018","unstructured":"Heesterman BL, de Pont LM, van der Mey AG, Bayley J-P, Corssmit EP, Hes FJ, Verbist BM, van Benthem PPG, Jansen JC. Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers. Eur J Hum Genet. 2018;26(9):1339\u201347.","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"3641_CR42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292(8):943\u201351.","journal-title":"JAMA"},{"issue":"1","key":"3641_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ejhg.2009.112","volume":"18","author":"EF Hensen","year":"2010","unstructured":"Hensen EF, Jansen JC, Siemers MD, Oosterwijk JC, Vriends AH, Corssmit EP, Bayley JP, van der Mey AG, Cornelisse CJ, Devilee P. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family. Eur J Hum Genetics: EJHG. 2010;18(1):62\u20136.","journal-title":"Eur J Hum Genetics: EJHG"},{"issue":"5","key":"3641_CR44","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1210\/jc.2007-1989","volume":"93","author":"P Pigny","year":"2008","unstructured":"Pigny P, Vincent A, Cardot Bauters C, Bertrand M, de Montpreville VT, Crepin M, Porchet N, Caron P. Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation. J Clin Endocrinol Metab. 2008;93(5):1609\u201315.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03641-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03641-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03641-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T07:10:31Z","timestamp":1735888231000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03641-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3641"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03641-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Beijing Tiantan Hospital (NO.KY2023-131-01). Prior to blood collection for DNA analysis, all Patients and their families participated voluntarily and signed informed consent forms, and the study was performed in accordance with the Helsinki II declaration. Informed consent was obtained from all the study subjects before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}